Study of the QOL Evaluation of Trelagliptin in Patients With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2017-10-21
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the reduction in treatment burden during 12 weeks of
trelagliptin administration in patients with type 2 diabetes on diet and exercise therapy
only.